MedTrace Logo

A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis

NCT04160351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-05-19

No results posted yet for this study

Summary

This is an open label, cross-over group, single-centre randomised controlled trial comparing Medium Cut Off Dialyser with High Flux Dialyser in patients with end-stage renal disease on chronic haemodialysis.

Conditions

  • Hemodialysis-Associated Amyloidosis
  • Dialysis Amyloidosis
  • Quality of Life

Interventions

DEVICE

Theranova 400

medium cut-off dialyser

DEVICE

Elisio-19H

high flux dialyser

Sponsors & Collaborators

  • Selayang Hospital

    lead OTHER_GOV

Principal Investigators

  • Hin Seng Wong, MD · Ministry of Health, Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2020-06-01
Completion
2021-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04160351 on ClinicalTrials.gov